Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Revenue (2016 - 2025)

Medifast (MED) has disclosed Revenue for 16 consecutive years, with $75.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 36.9% year-over-year to $75.1 million, compared with a TTM value of $385.8 million through Dec 2025, down 35.96%, and an annual FY2025 reading of $385.8 million, down 35.96% over the prior year.
  • Revenue was $75.1 million for Q4 2025 at Medifast, down from $89.4 million in the prior quarter.
  • Across five years, Revenue topped out at $453.3 million in Q2 2022 and bottomed at $75.1 million in Q4 2025.
  • Average Revenue over 5 years is $259.2 million, with a median of $266.0 million recorded in 2023.
  • The sharpest move saw Revenue surged 90.89% in 2021, then tumbled 49.93% in 2024.
  • Year by year, Revenue stood at $377.8 million in 2021, then dropped by 10.74% to $337.2 million in 2022, then plummeted by 43.36% to $191.0 million in 2023, then plummeted by 37.7% to $119.0 million in 2024, then crashed by 36.9% to $75.1 million in 2025.
  • Business Quant data shows Revenue for MED at $75.1 million in Q4 2025, $89.4 million in Q3 2025, and $105.6 million in Q2 2025.